Verified earnings results

Inhibrx Biosciences Q3 2026 Earnings Results

Direct answer

Inhibrx Biosciences reported Q3 2026 results on November 13, 2026.

Revenue was 2,000,000. EPS beat the estimate by 4.41%.
The result is verified against Verified earnings source.
Verified earnings source

Get free Inhibrx Biosciences email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Earnings date
November 13, 2026
Reported timing
After the US market closes
EPS estimate
-2.5735
Reported EPS
-2.46
Revenue
2,000,000
EPS surprise
EPS beat the estimate by 4.41%.

Read the frequently asked questions.

When did Inhibrx Biosciences report Q3 2026 earnings?

Inhibrx Biosciences reported on November 13, 2026. The reported timing was after the us market closes.

What is the available EPS estimate for Inhibrx Biosciences?

The verified record provides an EPS estimate of -2.5735.

Has Inhibrx Biosciences reported the Q3 2026 result?

Revenue was 2,000,000. EPS beat the estimate by 4.41%.

Which source supports this Inhibrx Biosciences earnings record?

The earnings record identifies Verified earnings source as its source. Missing values are not estimated.